Mechanism of augmented graft survival in mice after ALS and bone marrow infusion
Wood, M.L.; Heppner, G.; Gozzo, J.J.; Monaco, A.P.
Transplantation Proceedings 5(1): 691-696
1973
ISSN/ISBN: 0041-1345 PMID: 4572128 Document Number: 60870
Document emailed within 1 workday
Related Documents
Du, B.; Li, D-peng.; Xu, K-lin.; Pan, X-ying. 2005: Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice Chinese Medical Journal 118(6): 474-479Davies, S.M.; Weisdorf, D.J.; Haake, R.J.; Kersey, J.H.; McGlave, P.B.; Ramsay, N.K.; Blazar, B.R. 1994: Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation Bone Marrow Transplantation 14(1): 73-77
Vriesendorp, H.M. 1982: Bone marrow graft survival after total body irradiation in dogs Transplantation 34(5): 312
Olszewski, W.L.; Lukomska, B.; Durlik, M.; Namyslowski, A.; Cybulska, E. 1994: Bone marrow cells transplanted in suspension or in vascularized bone graft repopulate not only bone marrow but also lymphoid organs Transplantation Proceedings 26(6): 3319-3320
Nevo, S.; Enger, C.; Swan, V.; Wojno, K.J.; Fuller, A.K.; Altomonte, V.; Braine, H.G.; Noga, S.J.; Vogelsang, G.B. 1999: Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival Transplantation 67(5): 681-689
Brok, H.P.; Heidt, P.J.; van der Meide, P.H.; Zurcher, C.; Vossen, J.M. 1993: Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice Journal of Immunology 151(11): 6451-6459
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
Cudkowicz, G.; Bennett, M.; Cudkowicz, G.; Bennett, M. 2015: Pillars Article: Peculiar Immunobiology of Bone Marrow Allografts: I. Graft Rejection by Irradiated Responder Mice. J Exp Med. 1971. 134: 83-102 Journal of Immunology 195(7): 2926-2945
Oluwole, S.F.; Engelstad, K.; Hardy, M.A. 1992: Kinetics of prevention of graft-versus-host disease and bone marrow rejection by ultraviolet B modulation of bone marrow inoculum Transplantation Proceedings 24(6): 2858-2859
Oudshoorn, M.; Falkenburg, J.H.; Ebeling, L.J.; Haak, H.L.; Wijermans, P.W.; Fibbe, W.E.; Willemze, R.; van Rood, J.J. 1996: Unrelated bone marrow transplantation as a rescue procedure following inadvertent loss of an autologous bone marrow graft Bone Marrow Transplantation 18(2): 461-463
Chowdhury, N.C.; Jin, M.X.; Hardy, M.A.; Oluwole, S.F. 1993: Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells Transplantation Proceedings 25(1 Pt 1): 475-476
Amiel, J.L.; Mathe, G.; Schwarzenberg, L.; Schneider, M.; Choay, J.; Trolard, P.; Hayat, M.; Schlumberger, J.R.; Jasmin, C. 1970: Allogenic bone marrow graft after conditioning with only antilymphocytic serum in states of bone marrow aplasias La Presse Medicale 78(40): 1727-1734
Bolger, G.B.; Sullivan, K.M.; Storb, R.; Witherspoon, R.P.; Weiden, P.L.; Stewart, P.; Sanders, J.; Meyers, J.D.; Martin, P.J.; Doney, K.C. 1986: Second marrow infusion for poor graft function after allogeneic marrow transplantation Bone Marrow Transplantation 1(1): 21-30
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696
Moussalem, M.; Esperou Bourdeau, H.; Devergie, A.; Baruchel, A.; Ribaud, P.; Socie, G.; Parquet, N.; Traineau, R.; Hirsch, I.; Schaison, G. 1995: Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease Bone Marrow Transplantation 15(6): 943-947
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1996: Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion Transplantation Proceedings 28(6): 3269
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1997: Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow Transplantation 63(3): 359-364
Jansen, J.; Goselink, H.M.; Veenhof, W.F.; Zwaan, F.E.; Blotkamp, C. 1983: The impact of the composition of the bone marrow graft on engraftment and graft-versus-host disease Experimental Hematology 11(10): 967-973
Greenberger, J.S.; Shadduck, R.K.; Jaenisch, R.; Waheed, A.; Sakakeeny, M.A. 1981: Effects of murine leukemia virus infection on long-term hematopoiesis in vitro emphasized by increased survival of bone marrow cultures derived from BALB/Mo mice Cancer Research 41(9 Part 1): 3556-3565
Haanen, C.; De Witte, T.; Plas, A.; Schattemberg, T. 1991: Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation Haematologica 76 Suppl. 1: 22-28